Kazuya Shimoda

机构：University of Miyazaki · ORCID：0000-0002-2555-8188

发表论文 476 篇 · 总被引 11569 次 · h-index 51

代表论文

• JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN) (2024 · International Journal of Hematology · 被引 14)
• Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study (2025 · The Lancet Haematology · 被引 9)
• Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera (2025 · Pharmacology Research & Perspectives · 被引 9)
• Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis (2025 · Scientific Reports · 被引 5)
• Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms (2025 · Current Hematologic Malignancy Reports · 被引 4)
• Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice (2025 · International Journal of Hematology · 被引 4)